P3 Health Partners (NASDAQ:PIII) Downgraded by BTIG Research to Neutral

P3 Health Partners logo with Medical background

BTIG Research cut shares of P3 Health Partners (NASDAQ:PIII - Free Report) from a buy rating to a neutral rating in a report published on Monday morning, Marketbeat.com reports.

Separately, Lake Street Capital reduced their price target on shares of P3 Health Partners from $9.00 to $4.50 and set a buy rating on the stock in a research report on Thursday, March 14th.

View Our Latest Research Report on P3 Health Partners

P3 Health Partners Trading Down 14.1 %

Shares of NASDAQ PIII traded down $0.15 during midday trading on Monday, reaching $0.88. 416,470 shares of the stock were exchanged, compared to its average volume of 381,953. The business has a 50-day simple moving average of $1.06 and a two-hundred day simple moving average of $1.27. The company has a market capitalization of $277.02 million, a price-to-earnings ratio of -1.36 and a beta of 1.04. P3 Health Partners has a 12 month low of $0.66 and a 12 month high of $5.56. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.67 and a quick ratio of 0.67.

Institutional Investors Weigh In On P3 Health Partners

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PIII. The Manufacturers Life Insurance Company acquired a new position in shares of P3 Health Partners during the 4th quarter worth about $25,000. Marietta Investment Partners LLC acquired a new position in shares of P3 Health Partners during the 1st quarter worth about $26,000. Squarepoint Ops LLC acquired a new position in shares of P3 Health Partners during the 4th quarter worth about $31,000. Walleye Trading LLC acquired a new position in shares of P3 Health Partners during the 2nd quarter worth about $34,000. Finally, State Board of Administration of Florida Retirement System acquired a new position in shares of P3 Health Partners during the 2nd quarter worth about $34,000. 7.75% of the stock is currently owned by institutional investors and hedge funds.


P3 Health Partners Company Profile

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

Featured Articles

Should you invest $1,000 in P3 Health Partners right now?

Before you consider P3 Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.

While P3 Health Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: